Jamie Beachy, Steve Elfrink, Martha Hammel, Nate Howard, Meaghan Len Richmond, Barine Majewska
As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.
Panel: New psychedelic entrepreneurs discuss unique business structures and financial strategies aligning with values and purpose, rejecting traditional models for innovative, purpose-driven for-profit ventures.
Daniel Tarockoff, Scarlet Masius
Vicky Dulai of Compassion For Addiction moderates a discussion with Amy Emerson of MAPS Public Benefit Corporation and Rachel Yehuda of Icahn School of Medicine on leadership in the psychedelic
Rachel Yehuda
Harms of drug prohibition include trauma and research prevention. Policies should shift focus from criminalizing psychedelics to supporting safe, beneficial use, fostering an imaginative world for future generations.
Ariel Clark, Christopher Medina-Kirchner, Roman Haferd, Betty Aldworth, Paula Graciela Kahn
Expansion of psychedelic policy in the US includes decriminalization, adult use regulations, and increased research funding. Elected state lawmakers discuss challenges, opportunities, and lessons from proposed psychedelic legislation.
Rep La Shawn Ford (IL), Rep Alex Dominguez (TX), Tamar Todd
Philanthropy and investors can support crucial psychedelic research and initiatives beyond commercial interests to shape the field and promote equity and social value in the psychedelic economy.
Sandy Samberg
International drug policy, historically mirroring US prohibitionist approach, is evolving. Leaders propose regulatory solutions in context of broader drug reform for unified post-prohibition world.
Steve Rolles, Kasia Malinowska
TREAT California initiative aims to transform mental healthcare in California with $5 Billion funding for psychedelic medicine research and access, inspired by successful stem cell agency model.
Jeannie Moller Fontana
"Prescription X: The Rick Doblin Story" documents Dr. Rick Doblin's quest with MAPS to legalize MDMA and psychedelics for therapy, culminating in a revealing film by Nirvan and Dream Mullick.
Nirvan Mullick, Dream Mullick
Harm reduction superheroes delve into risk mitigation and benefit maximization, exploring mindset, setting, and substances for safer drug experiences and systemic change.
Mitchell Gomez, Phoenix aka Mohawk Greene